Eli Lilly
Eli Lilly UK is the British subsidiary of the global pharmaceutical company Eli Lilly and Company, developing breakthrough treatments in diabetes, obesity, oncology, immunology, and neuroscience. Key products include Mounjaro (tirzepatide) for type 2 diabetes and chronic weight management, Trulicity (dulaglutide) for type 2 diabetes, Verzenio (abemaciclib) for hormone receptor-positive breast cancer, Taltz (ixekizumab) for psoriasis and psoriatic arthritis, and Emgality (galcanezumab) for migraine prevention.
How to Contact Eli Lilly
Phone
+44 (0)1256 315000Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
